NASDAQ Companies

CUPERTINO, CA, March 01, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX) announced that the company will […]

HIGH POINT, N.C., March 01, 2024 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused […]

– Topline data from the Phase 1 portion of Phase 1/2a trial of IMM-1-104 expected in March 2024 – – […]

BOSTON, March 01, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]

— Maturing into clinical-stage company; on-track to file IND application or CTA for PM359 in 1H 2024, with initial data […]

Reports continued enrollment in the second part of the Phase 3 clinical trial in bunionectomy Remains on track to announce […]

SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology […]

Atlantica Reports 2023 Financial Results Net profit for 2023 attributable to the Company was $43.4 million, compared with a net […]

EDINBURG, Va., March 01, 2024 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced that it […]

BEIJING, China, March 01, 2024 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), […]